W. R. Grace & Co

About W. R. Grace & Co

Grace, built on talent, technology and trust, is a premier specialty chemicals company that provides innovative products, technologies and services that support pharmaceutical development and manufacturing. As a worldwide leader in specialty silica gel manufacturing, we offer unmatched quality and reproducibility of our fine chemicals, chromatography resins, formulation excipients, and active ingr...

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Contact info

Products from W. R. Grace & Co (3)

  • Custom Fine Chemical Manufacturing

    Product Custom Fine Chemical Manufacturing

    Our comprehensive portfolio of services, integrated manufacturing, and regulatory leadership differentiates us as a leading contract development and manufacturing partner. With a proven ability to deliver solutions to complex challenges, Grace’s FCMS supports the entire small molecule development cycle fro...
  • Purification and Formulation of Oily APIs and Omega-3s

    Product Purification and Formulation of Oily APIs and Omega-3s

    Grace resins and excipients improve purity and create better targeted and higher value formulations with enhanced bioavailability. Grace is solving purification and formulation issues in oily APIs and Omega-3s in high quality separation capabilities, customization, reliability and speed to market, and ...
  • Purification and Formulation of Cannabinoids (CBD)

    Product Purification and Formulation of Cannabinoids (CBD)

    Grace has developed and introduced a patented silica based carrier, SYLOID® XDP silica, to directly convert liquid ingredients such as CBD into solid dosage forms. Extracting and purifying CBD from the hemp plant is a multi-step process which focuses on removal of several undesirable impurities. Grace ...

W. R. Grace & Co Resources (2)

  • News Grace Completes Acquisition of Fine Chemistry Business

    June 01, 2021: W. R. Grace & Co. announced the completion of its acquisition of the Fine Chemistry Services business (“FCS”) of Albemarle Corporation (NYSE: ALB) for approximately $570 million, including $300 million paid in cash and $270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary.
  • Brochure Grace Pharmaceutical Solutions Brochure

    Learn more about Grace's unmatched quality and reproducibility of our fine chemicals, chromatography resins, formulation excipients, and active ingredient delivery technologies.